Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Bartter syndrome history and symptoms

Introduction

Main article: Bartter syndrome

Overview

Overview

Bartter syndrome is an autosomal recessive disorder that often presents in childhood and may be associated with stunted growth, mental retardation, hypokalemia, metabolic alkalosis, polyuria and polydipsia, normal to increased urinary calcium excretion, normal or mildly decreased serum magnesium concentration, hypophosphatemia and hypercalciuria.

History and Symptoms

History and Symptoms

Bartter syndrome is an autosomal recessive disorder that often presents in childhood and may be associated with the following clinical features:

The clinical manifestations are much less pronounced in heterozygotes.

  • Researchers induced mutations in the loop diuretic-sensitive sodium-potassium- chloride cotransporter (NKCC2). They found a normal range of blood pressure and fluid balance among heterozygous mice.[6]
References

References

  1. ↑ 1.0 1.1 Stein JH (1985). “The pathogenetic spectrum of Bartter’s syndrome”. Kidney Int. 28 (1): 85–93. doi:10.1038/ki.1985.123. PMIDΒ 4046329.
  2. ↑ 2.0 2.1 2.2 2.3 Bettinelli A, Bianchetti MG, Girardin E, Caringella A, Cecconi M, Appiani AC; et al. (1992). “Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes”. J Pediatr. 120 (1): 38–43. doi:10.1016/s0022-3476(05)80594-3. PMIDΒ 1731022.
  3. ↑ Dillon MJ, Shah V, Mitchell MD (1979). “Bartter’s syndrome: 10 cases in childhood. Results of long-term indomethacin therapy”. Q J Med. 48 (191): 429–46. PMIDΒ 120550.
  4. ↑ 4.0 4.1 Sann L, David L, Bernheim J, FranΓ§ois R (1978). “Hypophosphatemia and hyperparathyroidism in a case of Bartter’s syndrome”. Helv Paediatr Acta. 33 (3): 299–310. PMIDΒ 711493.
  5. ↑ “Bartter syndrome – Genetics Home Reference – NIH”.
  6. ↑ Takahashi N, Brooks HL, Wade JB, Liu W, Kondo Y, Ito S; et al. (2002). “Posttranscriptional compensation for heterozygous disruption of the kidney-specific NaK2Cl cotransporter gene”. J Am Soc Nephrol. 13 (3): 604–10. PMIDΒ 11856763.


Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]